Galectins as Cancer Biomarkers
AbstractGalectins are a group of proteins that bind β-galactosides through evolutionarily conserved sequence elements of the carbohydrate recognition domain (CRD). Proteins similar to galectins can be found in very primitive animals such as sponges. Each galectin has an individual carbohydrate binding preference and can be found in cytoplasm as well as in the nucleus. They also can be secreted through non-classical pathways and function extra-cellularly. Experimental and clinical data demonstrate a correlation between galectin expression and tumor progression and metastasis, and therefore, galectins have the potential to serve as reliable tumor markers. In this review, we describe the expression and role of galectins in different cancers and their clinical applications for diagnostic use. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Balan, V.; Nangia-Makker, P.; Raz, A. Galectins as Cancer Biomarkers. Cancers 2010, 2, 592-610.
Balan V, Nangia-Makker P, Raz A. Galectins as Cancer Biomarkers. Cancers. 2010; 2(2):592-610.Chicago/Turabian Style
Balan, Vitaly; Nangia-Makker, Pratima; Raz, Avraham. 2010. "Galectins as Cancer Biomarkers." Cancers 2, no. 2: 592-610.